phenoxybenzamine has been researched along with Adenocarcinoma, Basal Cell in 3 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Liang, P | 1 |
Li, J | 1 |
Chen, J | 1 |
Lu, J | 2 |
Hao, Z | 1 |
Shi, J | 1 |
Chang, Q | 1 |
Zeng, Z | 1 |
Chung, FH | 1 |
Chiang, YR | 1 |
Tseng, AL | 1 |
Sung, YC | 1 |
Huang, MC | 1 |
Ma, N | 1 |
Lee, HC | 1 |
Paris, H | 1 |
Taouis, M | 1 |
Galitzky, J | 1 |
3 other studies available for phenoxybenzamine and Adenocarcinoma, Basal Cell
Article | Year |
---|---|
Immunoprognostic model of lung adenocarcinoma and screening of sensitive drugs.
Topics: Adenocarcinoma; Carrier Proteins; Histocompatibility Antigens Class I; Humans; Lung; Lung Neoplasms; | 2022 |
Functional Module Connectivity Map (FMCM): a framework for searching repurposed drug compounds for systems treatment of cancer and an application to colorectal adenocarcinoma.
Topics: Adenocarcinoma; Algorithms; Colorectal Neoplasms; Drug Repositioning; Epistasis, Genetic; Ethacrynic | 2014 |
In vitro study of alpha 2-adrenoceptor turnover and metabolism using the adenocarcinoma cell line HT29.
Topics: Adenocarcinoma; Adenylyl Cyclases; Adrenergic alpha-Antagonists; Animals; Cell Line; Cell Membrane; | 1987 |